Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7851 to 7900 of 8897 results

  1. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG58)

    We have moved Diagnostics guidance 58 to become HealthTech guidance 719. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  2. Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M (DG6)

    We have moved Diagnostics guidance 6 to become HealthTech guidance 292. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  3. Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) (DG60)

    We have moved Diagnostics guidance 60 to become HealthTech guidance 729. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  4. Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome (DG62)

    We have moved Diagnostics guidance 62 to become HealthTech guidance 735. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  5. Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer (DG8)

    We have moved Diagnostics guidance 8 to become HealthTech guidance 315. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  6. Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (DG61)

    We have moved Diagnostics guidance 61 to become HealthTech guidance 730. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  7. EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer (DG9)

    We have moved Diagnostics guidance 9 to become HealthTech guidance 316. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  8. SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (DG7)

    This guidance has been updated and replaced by NICE healthtech guidance 598.

    Withdrawn guidance

  9. Endovascular closure of perimembranous ventricular septal defect (IPG172)

    This guidance has been updated and replaced by NICE HealthTech guidance 213.

    Withdrawn guidance

  10. Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum (IPG176)

    We have moved interventional procedures guidance 176 to become HealthTech guidance 114. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  11. Percutaneous cementoplasty for palliative treatment of bony malignancies (IPG179)

    We have moved interventional procedures guidance 179 to become HealthTech guidance 117. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery (IPG177)

    We have moved interventional procedures guidance 177 to become HealthTech guidance 115. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer (IPG174)

    We have moved interventional procedures guidance 174 to become HealthTech guidance 113. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Percutaneous laser therapy for fetal tumours (IPG180)

    We have moved interventional procedures guidance 180 to become HealthTech guidance 118. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  15. Tonsillectomy using ultrasonic scalpel (IPG178)

    We have moved interventional procedures guidance 178 to become HealthTech guidance 116. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  16. Bone-anchored cystourethropexy (IPG18)

    We have moved interventional procedures guidance 18 to become HealthTech guidance 6. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  17. Ultrasound guided foam sclerotherapy for varicose veins (IPG182)

    This guidance has been updated and replaced by NICE interventional procedure guidance 440.

    Withdrawn guidance

  18. Percutaneous occlusion of left atrial appendage (IPG181)

    This guidance has been updated and replaced by NICE HealthTech guidance 222.

    Withdrawn guidance

  19. Prosthetic intervertebral disc replacement (IPG100)

    This guidance has been updated and replaced by NICE HealthTech guidance 197.

    Withdrawn guidance

  20. Uterine artery embolisation for fibroids (IPG1)

    This guidance has been updated and replaced by NICE HealthTech guidance 240.

    Withdrawn guidance

  21. Stent-graft placement in abdominal aortic aneurysm (IPG10)

    This guidance has been updated and replaced by NICE interventional procedure guidance 163.

    Withdrawn guidance

  22. Wireless capsule endoscopy for investigation of the small bowel (IPG101)

    We have moved interventional procedures guidance 101 to become HealthTech guidance 62. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  23. Gastroelectrical stimulation for gastroparesis (IPG103)

    Interventional procedures, IPG103 - Issued: December 2004 --> This guidance has been updated and replaced by NICE interventional procedure guidance 489.

    Withdrawn guidance

  24. Impedance-controlled endometrial ablation for menorrhagia (IPG104)

    Summary --> This guidance has been updated and replaced by NICE guideline CG44.

    Withdrawn guidance

  25. Coil embolisation of unruptured intracranial aneurysms (IPG105)

    We have moved interventional procedures guidance 105 to become HealthTech guidance 63. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  26. Laser in situ keratomileusis (LASIK) for the treatment of refractive errors (IPG102)

    This guidance has been replaced by NICE interventional procedure guidance 164.

    Withdrawn guidance

  27. Coil embolisation of ruptured intracranial aneurysms (IPG106)

    We have moved interventional procedures guidance 106 to become HealthTech guidance 64. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  28. Transobturator foramen procedures for stress urinary incontinence (IPG107)

    The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on transobturator foramen procedures for stress incontinence in January 2005. This guidance has been withdrawn as the use of this procedure is now covered in NICE guideline CG40. NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme.

    Withdrawn guidance

  29. Laparoscopic radical hysterectomy for early stage cervical cancer (IPG338)

    This guidance has been updated and replaced by NICE HealthTech guidance 565.

    Withdrawn guidance

  30. Fertility: assessment and treatment for people with fertility problems (CG11)

    This guideline has been updated and replaced by NICE guideline CG156.

    Withdrawn guideline

  31. Anaemia management in people with chronic kidney disease (CG114)

    This guideline has been updated and replaced by NICE guideline NG8.

    Withdrawn guideline

  32. Crohn's disease: management (CG152)

    This guidance has been updated and replaced by NICE guideline NG129.

    Withdrawn guideline

  33. Ectopic pregnancy and miscarriage: diagnosis and initial management (CG154)

    This guidance has been updated and replaced by NICE guideline NG126

    Withdrawn guideline

  34. Epilepsies: diagnosis and management (CG137)

    This guidance has been updated and replaced by NICE guideline NG217.

    Withdrawn guideline

  35. Familial breast cancer (CG14)

    This guidance has been updated and replaced by NICE guideline CG41.

    Withdrawn guideline

  36. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

    This guidance has been updated and replaced by NICE guideline NG158.

    Withdrawn guideline

  37. Neonatal infection (early onset): antibiotics for prevention and treatment (CG149)

    This guidance has been updated and replaced by NICE guideline NG195.

    Withdrawn guideline

  38. Diagnosis and management of type 1 diabetes in children, young people and adults (CG15)

    This guidance has been updated and replaced by NICE guidelines NG17, NG18 and NG19.

    Withdrawn guideline

  39. Hypertension in adults: diagnosis and management (CG127)

    This guidance has been updated and replaced by NICE guideline NG136.

    Withdrawn guideline

  40. Multiple pregnancy: antenatal care for twin and triplet pregnancies (CG129)

    This guideline has been updated and replaced by NICE guideline NG137

    Withdrawn guideline

  41. Caesarean section (CG13)

    This guideline has been updated and replaced by NICE guideline CG132.

    Withdrawn guideline

  42. Hyperglycaemia in acute coronary syndromes: management (CG130)

    This guideline has been replaced by NICE guideline NG185.

    Withdrawn guideline

  43. Colorectal cancer: diagnosis and management (CG131)

    This guidance has been updated and replaced by NICE guideline NG151.

    Withdrawn guideline

  44. Caesarean section (CG132)

    This guidance has been updated and replaced by NICE guideline NG192 and the recommendations on multiple pregnancy have been updated and replaced by NICE guideline NG137. 

    Withdrawn guideline

  45. Self-harm in over 8s: long-term management (CG133)

    This guidance has been updated and replaced by NICE guideline NG225.

    Withdrawn guideline

  46. Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia (CG157)

    This guidance has been updated and replaced by NICE guideline NG203.

    Withdrawn guideline

  47. Self-harm in over 8s: short-term management and prevention of recurrence (CG16)

    This guidance has been updated and replaced by NICE guideline NG225.

    Withdrawn guideline

  48. Fever in under 5s: assessment and initial management (CG160)

    This guidance has been updated and replaced by NICE guideline NG143.

    Withdrawn guideline

  49. Falls in older people: assessing risk and prevention (CG161)

    This guideline has been updated and replaced by NICE guideline NG249.

    Withdrawn guideline

  50. Stroke rehabilitation in adults (CG162)

    This guidance has been updated and replaced by NICE guideline NG236.

    Withdrawn guideline